Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Route 92 Medical, Inc.

Route 92 Medical Files Patent Infringement Suit Against Balt
From Route 92 Medical, Inc.
Via GlobeNewswire
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Appoints Medtech Industry Veterans Mitch Hill and Lucas Buchanan to its Board of Directors
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke
From Route 92 Medical, Inc.
Via GlobeNewswire
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Gains EU and MDSAP Certification for its Neurovascular Stroke-Intervention-Focused Product Portfolio
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces $50 Million Series F Extension Equity Financing
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces FDA 510(k) Clearance for FreeClimb 54 Reperfusion System
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces the 100th Patent for its Neurovascular Intervention Portfolio
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Impressive Clinical Results for its Tenzing® Technology.
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer
From Route 92 Medical, Inc.
Via GlobeNewswire
Tickers NTUS
Route 92 Medical Announces Publication of a Retrospective Study in the Interventional Neuroradiology Journal
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Receives the First FDA Clearance for a Complete Stroke Treatment System
From Route 92 Medical, Inc.
Via GlobeNewswire
Route 92 Medical Announces the 80th Patent for Monopoint Operating Platform
From Route 92 Medical, Inc.
Via Business Wire
Route 92 Medical Announces Expansion to New Manufacturing Site in Salt Lake City, Utah
From Route 92 Medical, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.